Stock A010600 WELLBIOTEC CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Wellbiotec Co., Ltd.

Equities

A010600

KR7010600005

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 04/04/2024 BST 		5-day change 1st Jan Change
545 KRW -6.84% Intraday chart for Wellbiotec Co., Ltd. -.--% -54.77%
05-16 Wellbiotec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-16 Wellbiotec Co., Ltd.(KOSE:A010600) dropped from S&P Global BMI Index CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Wellbiotec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Wellbiotec Co., Ltd.(KOSE:A010600) dropped from S&P Global BMI Index
CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Wellbiotec Co., Ltd. announced that it has received KRW 8.00000001 billion in funding from K-Impact Fund
CI
Wellbiotec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Wellbiotec Co., Ltd. announced that it has received KRW 3 billion in funding from KH Feelux Co., Ltd.
CI
Wellbiotec Co., Ltd. announced that it has received KRW 10 billion in funding from Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank, Investment Arm
CI
Wellbiotec Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank, Investment Arm
CI
KOSSEN Co., Ltd. cancelled the acquisition of additional 14.57% stake in Biogenicskorea Co., Ltd. from a group of sellers.
CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Wellbiotec Co., Ltd. announced that it expects to receive KRW 3 billion in funding from KH Feelux Co., Ltd.
CI
Wellbiotec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Wellbiotec Co., Ltd. announced that it expects to receive KRW 9.99999891 billion in funding from Shin-oh Electronic Co.Ltd and another investor
CI
Wellbiotec Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Wise Pacific Holdings Limited and another investor
CI
Wellbiotec Co., Ltd. cancelled the transaction announced on January 2, 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A010600 Stock
  4. News Wellbiotec Co., Ltd.